Medical news
Each update carries a summary written by WellCareChina with AI assistance, the source name, the date, and a link to the original.
-
AI-assisted summary
Chinese eye team performs cataract surgery in Uzbekistan, Xinhua reports
Xinhua reported on 12 September 2026 that a team from Peking University People’s Hospital sent to Samarkand under a National Health Commission exchange programme planned to perform 300 free cataract operations and to demonstrate surgery for glaucoma and corneal disease. The report quotes the team’s deputy director of ophthalmology saying that more than 200 operations […]
-
AI-assisted summary
Beijing’s health commission reports on the 2026 services-trade health showcase
The Beijing Municipal Health Commission said a release event for the health-services section of the 2026 China International Fair for Trade in Services was held at Shougang Park on 10 September 2026. The commission’s account says the event published lists of advances in health service trade and in capital health research, promoted an AI-in-medicine project […]
-
AI-assisted summary
Foreign patients seek out China’s medical advances, Xinhua reports
Xinhua reported on 9 September 2026 that a 12-year-old patient from Russia received a domestically developed closed-loop spinal cord neural interface at the Second Affiliated Hospital of Zhejiang University School of Medicine in Hangzhou, and took assisted steps after three months of rehabilitation. The report cites National Health Commission figures of about 1.28 million visits […]
-
AI-assisted summary
China extends emergency heart-attack care to township clinics, Xinhua reports
Xinhua reported on 4 September 2026 that a 72-year-old man with an acute myocardial infarction received intravenous thrombolysis at a township health centre in Hefeng County, Hubei, one of 1,404 chest pain treatment units the province has set up over five years. The report cites provincial figures of nearly 3,000 thrombolysis procedures at 320 grassroots […]
-
AI-assisted summary
Research highlight: an early trial of an mRNA vaccine in EBV-linked tumours
A research highlight in Cancer Communications on 21 August 2026 summarises an early-stage trial (NCT05714748) of WGc-043, an mRNA vaccine developed by WestGene Biopharma, in patients with Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma and natural killer/T-cell lymphoma. The highlight reports disease control rates of 66.67% and 57.14% respectively and a favourable tolerability profile, and notes that […]
-
AI-assisted summary
Beijing reports growth in drug trial capacity
The Beijing Municipal Health Commission said on 14 August 2026 that drug trials led by Beijing institutions rose from 583 in 2020, 19.1 percent of the national total, to 1,077 in 2025, or 27.4 percent, citing the Centre for Drug Evaluation’s annual report on drug registration trials in China. It also reported that Beijing institutions […]
-
AI-assisted summary
Shanghai’s 2026-2030 health plan backs international medical services and medical travel
Shanghai’s municipal government issued its health development plan for the 2026-2030 period on 31 July 2026. The plan calls for steadily advancing pilot international medical services and cultivating internationally competitive medical-travel brands, for cooperating with organisations including the World Health Organization, and for adjusting the programme that sends Chinese medical teams to Morocco. Its indicator […]
-
AI-assisted summary
Hainan tightens oversight of drugs imported for urgent clinical need
Hainan’s medical products administration issued a notice on 23 July 2026 on supervising medicines and devices imported for urgent clinical need into the Boao Lecheng pilot zone. Designated hospitals must keep full procurement, storage, use and follow-up records, obtain informed consent that sets out the product’s status and that no equivalent domestic product is available, […]
-
AI-assisted summary
Phase 2 trial pairs short-course radiotherapy with immunotherapy in rectal cancer
A randomised phase 2 trial published in Cancer Communications on 23 July 2026 tested short-course radiotherapy followed by chemotherapy, with or without the PD-1 inhibitor tislelizumab, in patients starting treatment for locally advanced rectal cancer. Of 111 patients who started treatment, 89 had surgery; the pathological complete response rate was 45.3% with tislelizumab and 27.6% […]
-
AI-assisted summary
PUMCH opens its International Medical Department to diplomats and businesses
Peking Union Medical College Hospital said its International Medical Department at the Dongdan campus held an open day on 17 July 2026 for about 30 guests from embassies, companies and media. The hospital’s account says the department has its own outpatient and inpatient facilities with private rooms and suites, day, evening, weekend and by-appointment clinics, […]